Hizentra is an Ig* therapy that provides proven PI protection with the convenience of self-administration, so you can focus on everyday living


When treating PI, what's the difference between Hizentra and intravenous Ig (IVIg)?

With Hizentra, an IV is not involved. Hizentra treats primary immune deficiency (PI) with subcutaneous infusions, which means you can self-administer by infusing just under the skin, not into a vein, after receiving training from your doctor.

Hizentra gives you steady Ig levels for consistent PI protection, with less volume per dose plus flexible dosing options to fit your lifestyle (from daily to once every 2 weeks).

Hizentra is a prescription medicine used to treat PI in patients 2 years and older.

Join us for a free, live educational program for PI patients and their caregivers!

These programs feature a presentation from a trained nurse and stories from a patient just like you.
Watch a video below to learn more.

Join online: Take part in our live webinar series where you can ask questions and join in the discussion.

Register for an online event 

Support programs to help you get started

CSL Behring Premier Start logo

With Premier Start, you can receive:

  • A free 1-month supply of Hizentra and infusion equipment
  • Free at-home visits by a trained nurse
Discover how to start
Hizentra Co-Pay Relief

The Hizentra Co-Pay Relief program helps eligible people afford their therapy by assisting with monthly out-of-pocket expenses for Hizentra (up to $5,000 for each year, with no monthly cap). Most patients with commercial insurance pay $0 out-of-pocket.

See if you are eligible
CSL Behring Assurance logo

CSL Behring Assurance is a program that can help eligible patients continue to receive treatment even if they experience a lapse in third-party private health insurance.

Learn how it works
Welcome Kit

Sign up for a free Welcome Kit

This kit provides important resources to help you start and stay on Hizentra.

You are now leaving the current website.

Do you want to continue?

No Yes